AngioDynamics | ANGO - Operating Expenses


AngioDynamics reported $81.95M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 143.94M 3.22M Jun/2026
Boston Scientific USD 4.2B 49M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
ICU Medical USD 491.25M 8.59M Jun/2026
Inogen USD 49.14M 665K Sep/2024
J&J USD 17.83B 388M Jun/2026
Medtronic USD 7.92B 203M Jun/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Smiths GBP 822M 73M Dec/2026
Tandem Diabetes Care USD 268.35M 3.7M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Terumo JPY 222.33B 46.54B Jun/2026
Trinity Biotech USD 12.38M 2.44M Dec/2025